Mozafari, Parvin, Shahad Ali Ibrahim, Aabha Ajit Pawar, Zainab Ihsanalla Osman Ali, and Aditi Surendra Nair. “Balancing Long-Term Efficacy and Immunological Safety: Serious Infection Risk During Extended Ocrelizumab Therapy in Multiple Sclerosis”. Junior Researchers 4, no. 2 (July 13, 2026): 57–69. Accessed July 13, 2026. https://journals.4science.ge/index.php/jr/article/view/4978.